SHC1 and neoplasm: We now show that loss of cytotoxic T lymphocyte-driven anti-tumour immunity had no effect on tumour onset in MT/ShcA+/+ mice, consistent with published studies32, and minimally accelerated tumour onset in MT/Shc313F/313F mice.